BackAkebia Therapeutics Overview

Akebia Therapeutics Total Revenue

Revenue analysis for AKBA.

Quarterly Revenue

$53.54M
6.61% YoY

As of Mar 2026

Annual Revenue (TTM)

$232.40M
26.94% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading